WeVote
Log In

Bill

Bill

HB 1133

RELATING TO THE UNIFORM CONTROLLED SUBSTANCE ACT.

2026 Regular Session Introduced by Nadine Nakamura

HB 1133 updates Hawaii's controlled substance laws under the Uniform Act framework, affecting drug classifications, penalties, and state-federal enforcement coordination.

Carried over to 2026 Regular Session.
#uniformcontrolledsubstancesact
0
WeVote Research Nonpartisan
Bill Summary · HB 1133

Legislative bill overview

HB 1133 relates to Hawaii's adoption and implementation of the Uniform Controlled Substance Act (UCSA). The bill was introduced in January 2025 and has been referred to the Health and Judiciary committees for review. Without access to the specific bill text, the exact nature of proposed changes cannot be determined, though the referral suggests it involves substantive modifications to drug control statutes.

Why is this important

Hawaii's controlled substance laws directly affect criminal penalties, law enforcement practices, pharmaceutical regulation, and public health approaches to drug use and addiction. Changes to the UCSA can significantly impact incarceration rates, sentencing guidelines, and treatment accessibility across the state. The bill's focus on a "uniform" act suggests potential standardization with other states' drug policies.

Potential points of contention

  • Sentencing and penalties: Changes to mandatory minimums or felony thresholds for drug possession or distribution could either increase or decrease criminal consequences
  • Medical cannabis and emerging drugs: How the bill classifies newer substances (synthetic cannabinoids, fentanyl analogs) and whether it expands or restricts medical exemptions
  • Law enforcement priorities: Potential shifts in prosecutorial focus between minor possession offenses versus trafficking, affecting resource allocation and community policing approaches

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.